Canada's Voyageur Hires Fluor for Iodine Project Feasibility Study, Budgeted at $2.35 Million
Voyageur Pharmaceuticals Ltd. has engaged Fluor Corp. to complete comprehensive feasibility studies ...
Egypt's Minister of Industry Discusses Cooperation with Enterprise Ireland on 1,000 MW Solar PV and Other Initiatives
Egypt's Minister of Industry, Khalid Hashim, held talks with Ireland's Ambassador to Egypt, Aidan O'...
Germany's Evonik Sells Hanau Active Ingredient Facility to ProChem
Evonik has signed an agreement with the ProChem Group to sell part of its active ingredient producti...
Brazil's Funed invests R$10 million to convert abandoned building into biotechnology center, to start operations by year-end
The government of Minas Gerais has decided to convert an abandoned building in the Gameleira neighbo...
University of Michigan Creates Database of 50,000 Chemical Experiments to Accelerate Drug Discovery
The team of Tim Cernak at the University of Michigan College of Pharmacy has created an open-access ...
AbbVie to Acquire Apogee for $10.9 Billion to Strengthen Immunology Drug Pipeline
On June 22, local time, U.S. pharmaceutical company AbbVie announced it would acquire biotechnology ...
Spanish Team Discovers OLE Molecule Can Restore Microglial Function and Improve Cognition in Alzheimer's Disease
A research team from the Institute of Neuroscience at the Spanish National Research Council - Miguel...
China Approves World's First Solid Tumor CAR-T: CARsgen's Satri-cel for Market
The National Medical Products Administration (NMPA) has approved, through a priority review and appr...
European Medicines Agency Accepts Bayer’s Marketing Authorization Application for Ischemic Stroke Drug
The European Medicines Agency (EMA) has confirmed the acceptance and initiation of the evaluation of...
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, a deal aimed at strengthening th...
China's Ministry of Commerce Supports Foreign Investment in High-Quality Development of the Pharmaceutical Industry
Recently, China's Ministry of Commerce, together with the National Development and Reform Commission...
Sylvester Cancer Center in the U.S. Discovers New Pancreatic Cancer Target and Initiates Clinical Trial
Pancreatic cancer treatment has a new potential target. Researchers at the Sylvester Comprehensive C...
ChemT Biotechnology Secures $5 Million in Funding to Advance AI-Driven Biomanufacturing Platform
ChemT Biotechnology has announced the completion of a total of $5 million in funding, consisting of ...
Elevar Completes First Dosing in Phase 2 Study of Lirafugratinib in Non-Cholangiocarcinoma FGFR2 Solid Tumors in South Korea
Elevar Therapeutics announced that the first patients have been dosed in its global Phase 2 study ev...
Japan Approves Avastin as World's First Treatment for Neurofibromatosis Type 2
The Japanese Ministry of Health, Labour and Welfare has approved bevacizumab (Avastin) as an additio...
Evonik sells pharmaceutical raw material production assets in Hanau, Germany
Evonik has reached an agreement with the ProChem Group to sell its pharmaceutical raw material produ...
Neuland Laboratories Invests $20 Million in Process Development Lab
Neuland Laboratories plans to invest $20 million in building a dedicated 135,000-square-foot process...
US-based Boltz Partners with Takeda to Deploy Biomolecular AI Models
Boltz PBC, a US-based applied AI research lab, announced on June 18, 2026, a collaboration with Take...
CureGene Pharmaceutical's Antiplatelet Drug Evategrel Completes First Patient Dosing in U.S. Pivotal Trial
CureGene Pharmaceutical announced that its self-developed antiplatelet drug Evategrel (CG-0255) has ...
US Traws Pharma Advances Clinical Development of Long-Acting Anti-Influenza Drug TXM
Traws Pharma (Nasdaq: TRAW) is advancing the clinical development of its influenza candidate Tivoxav...
Singapore's Gero Secures $17 Million to Accelerate Aging Drug Development
Gero has secured $17 million in new funding to advance its AI-driven drug discovery platform focused...
AI at the University of Pennsylvania Discovers Antibiotic Candidates from Prions
A research team at the Perelman School of Medicine at the University of Pennsylvania has utilized ar...
Memento Completes $93 Million Series A Financing, Obtains Global License for Bispecific Antibody
Memento Medicines Completes $93 Million Series A Financing and Obtains Global License for MMT-205 Bi...
Siemens Healthineers Invests $30 Million in UK Radiopharmaceutical Facility
Siemens Healthineers will build a new radiopharmaceutical production base in the UK, with an investm...
South Korea's LG Chem Partners with UK's LabGenius to Develop AI-Powered Anti-Cancer Drugs
On June 18, South Korea's LG Chem announced a partnership with UK-based AI drug discovery company La...
China's ByteDance Spins Off AI Drug Discovery Unit, Seeks Independent Funding
ByteDance's artificial intelligence drug discovery unit has initiated a spin-off and is seeking inde...
Bayer Becomes Founding Member of International Society for Stem Cell Research Consortium
The International Society for Stem Cell Research (ISSCR) announced that Bayer has become a founding ...
EU Proposes Biotech Act to Balance Patent Protection and Generic Competition
The European Union plans to introduce the Biotech Act to enhance the global competitiveness of Europ...
Harbour BioMed and BioMap to Jointly Establish AI Pipeline R&D Company
On June 15, Harbour BioMed and BioMap jointly announced a multi-level, long-term comprehensive strat...
Guangzhou Atom High-Tech and Guangdong Radiation Protection Association Advance Fluorine-18 Drug Standards
Guangzhou Atom High-Tech Isotope Pharmaceutical Co., Ltd. recently exchanged views with the Guangdon...